Track topics on Twitter Track topics that are important to you
NEEDHAM, MA -- (Marketwired) -- 06/03/15 -- Insight Pharma Reports, a division of Cambridge Healthtech Institute, announces their Liquid Biopsy Report, focusing on this new emerging market for radically improving cancer management.
The report explores the background, history and basic research of liquid biopsy covering the three sample categories that dominate liquid biopsy today: circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs, also known as exosomes). Also included are the commercial aspects, market dynamics, and trends of liquid biopsy.
Report Highlights Include:
For more information visit: http://www.insightpharmareports.com/liquid-biopsy-report
About Insight Pharma Reports (http://www.insightpharmareports.com)
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. www.InsightPharmaReports.comFor more information: Kerri Kelley Insight Pharma Reports 781-972-1347 NEXT ARTICLE
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...